niclosamide has been researched along with Cancer of Head in 1 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, R | 1 |
| You, S | 1 |
| Hu, Z | 1 |
| Chen, ZG | 1 |
| Sica, GL | 1 |
| Khuri, FR | 1 |
| Curran, WJ | 1 |
| Shin, DM | 1 |
| Deng, X | 1 |
1 other study available for niclosamide and Cancer of Head
| Article | Year |
|---|---|
Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer.
Topics: Antineoplastic Agents; Base Sequence; Cell Line, Tumor; DNA Primers; Drug Synergism; ErbB Receptors; | 2013 |